Evaluating the effect of bowel preparation plus oral Rifaximin in Brachytherapy for endometrial and cervical Cancer
Ontology highlight
ABSTRACT: Intervention 1: Intervention group: bowel preparation with polyethilenglycol and bisacodyl tablet since 24 hours befor trearment and also rifaximin 400 mg BD since 7 days befor treatment. Intervention 2: Control group: bowel preparation with polyethilenglycol and bisacodyl tablet since 24 hours befor trearment.
Primary outcome(s): Rectal volume. Timepoint: Before(basement) and 7 days after oral Rifaximin. Method of measurement: HDR plus 3.0.8 brachytherapy , treatment planning, Bebig & Ziegler company.;Rectal Dose-volume parameters. Timepoint: Before(basement) and 7 days after oral Rifaximin. Method of measurement: HDR plus 3.0.8 brachytherapy treatment planning, Bebig & Ziegler company.
Study Design: Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention.
DISEASE(S): Condition 1: Endometrial Cancer. Condition 2: Cervical Cancer,Malignant Neoplasm Of Cervix Uteri, Unspecified,Malignant Neoplasm Of Endometrium
PROVIDER: 2501076 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA